Isotechnika Pharma Inc. Common Shares to Commence Trading on the TSX-V as of September 30, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

VICTORIA, British Columbia, Sept. 26, 2013 (GLOBE NEWSWIRE) -- Isotechnika Pharma Inc., now operating as Aurinia Pharmaceuticals Inc. (TSX:ISA) (“Aurinia” or the “Company”), announced that, further to its press release of September 23, 2013, its common shares will be delisted from the TSX at the close of business on September 27, 2013. The Company’s common shares will be posted for trading on the TSX Venture Exchange (“TSX-V”) at the opening of market on Monday, September 30. The Company’s common share trading symbol on the TSX-V will remain “ISA”.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC